| J0897 | Injection, denosumab, 1 mg | 15,660 | $20 | $281.9K |
| J3262 | Injection, tocilizumab, 1 mg | 34,000 | $10 | $170K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 4,680 | $30 | $158.9K |
| J9312 | Injection, rituximab, 10 mg | 2,090 | $60 | $133.8K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 12,500 | $10 | $125K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 23,800 | $1 | $95.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 560 | $80 | $47.3K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 5,250 | $10 | $42K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 180 | $80 | $15K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 120 | $110 | $12.8K |